Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Post by Trogarzonon Mar 12, 2023 7:42pm
108 Views
Post# 35333778

Move overthere

Move overthereThere is a perception that the company is not doing the necessary cuts to acheive their liquidity and cash flow targets.  It may not be the case but it is since we do not see it or ear it real time from the company.  They still adverstise jobs on their company site.  I mean does that send the right message.. no, not at all.  The returning Disney CEO Isner made it clear right of the bat that things were going to chnage and made some changes rapidly.  I don't feel like much has been done at Th apart from stating that the burnrate will come down from the Th1902 pause and that they will stage gate the potential restart of the trial in H1 maybe.  Like the burnrate would go back up instantly... how can you state anything of  the sort.  Now the Mararthon convenant scares are probably avoidable but investors are starting to panic now they ear about it and that is not going to reassure anyone in the mean time.  They must adress this now because if investors startt thinking they will be diluted to oblivion on top of consolidation thanks to their not meeting listing requirements.  All that to say that they better show the goods in the next month otherwise talking for myself I will bail and everyone here will be aware that day or that week.
<< Previous
Bullboard Posts
Next >>